Beijing Chunlizhengda Medical Instruments Co., Ltd. (688236.SS)
CNY 13.6
(-1.16%)
CNY 13.6
(-1.16%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 549.2 Million CNY | 0.58% |
| 2022 | 581.19 Million CNY | 23.84% |
| 2021 | 469.3 Million CNY | 35.67% |
| 2020 | 345.91 Million CNY | 11.7% |
| 2019 | 309.67 Million CNY | 53.96% |
| 2018 | 201.14 Million CNY | 48.73% |
| 2017 | 135.24 Million CNY | 56.58% |
| 2016 | 86.37 Million CNY | 3.56% |
| 2015 | 83.39 Million CNY | 48.12% |
| 2014 | 56.3 Million CNY | 34.39% |
| 2013 | 41.89 Million CNY | 24.99% |
| 2012 | 33.52 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 99.49 Million CNY | 24.55% |
| 2024 Q1 | 222.22 Million CNY | 3.28% |
| 2024 Q2 | 79.88 Million CNY | -64.05% |
| 2023 Q1 | 107.94 Million CNY | -54.02% |
| 2023 FY | 584.58 Million CNY | 0.58% |
| 2023 Q2 | 153.85 Million CNY | 42.53% |
| 2023 Q4 | 215.17 Million CNY | 82.66% |
| 2023 Q3 | 117.8 Million CNY | -23.43% |
| 2022 Q1 | 120.48 Million CNY | -29.61% |
| 2022 Q4 | 234.74 Million CNY | 137.7% |
| 2022 Q3 | 98.75 Million CNY | -25.14% |
| 2022 Q2 | 131.92 Million CNY | 9.5% |
| 2022 FY | 581.19 Million CNY | 23.84% |
| 2021 FY | 469.3 Million CNY | 35.67% |
| 2021 Q3 | 310.25 Million CNY | 205.72% |
| 2021 Q4 | 171.16 Million CNY | -44.83% |
| 2021 Q1 | 90.76 Million CNY | -11.91% |
| 2021 Q2 | 101.48 Million CNY | 11.81% |
| 2020 Q3 | 103.04 Million CNY | 23.17% |
| 2020 FY | 345.91 Million CNY | 11.7% |
| 2020 Q4 | 103.04 Million CNY | 0.0% |
| 2020 Q2 | 83.65 Million CNY | 24.35% |
| 2020 Q1 | 67.27 Million CNY | -26.5% |
| 2019 Q3 | 91.52 Million CNY | 35.88% |
| 2019 Q2 | 67.35 Million CNY | 0.0% |
| 2019 Q4 | 91.52 Million CNY | 0.0% |
| 2019 Q1 | 67.35 Million CNY | 10.15% |
| 2019 FY | 309.67 Million CNY | 53.96% |
| 2018 Q2 | 39.77 Million CNY | 0.0% |
| 2018 FY | 201.14 Million CNY | 48.73% |
| 2018 Q4 | 61.15 Million CNY | 0.0% |
| 2018 Q3 | 61.15 Million CNY | 53.72% |
| 2018 Q1 | 39.77 Million CNY | -6.93% |
| 2017 Q3 | 42.74 Million CNY | 56.66% |
| 2017 Q2 | 27.28 Million CNY | 0.0% |
| 2017 FY | 135.24 Million CNY | 56.58% |
| 2017 Q4 | 42.74 Million CNY | 0.0% |
| 2017 Q1 | 27.28 Million CNY | 18.09% |
| 2016 Q2 | 21.8 Million CNY | -0.0% |
| 2016 FY | 86.37 Million CNY | 3.56% |
| 2016 Q3 | 23.1 Million CNY | 5.95% |
| 2016 Q1 | 21.8 Million CNY | 2.25% |
| 2016 Q4 | 23.1 Million CNY | 0.0% |
| 2015 Q4 | 21.32 Million CNY | 0.0% |
| 2015 Q2 | 19.64 Million CNY | 0.0% |
| 2015 Q3 | 21.32 Million CNY | 8.53% |
| 2015 Q1 | 19.64 Million CNY | 38.92% |
| 2015 FY | 83.39 Million CNY | 48.12% |
| 2014 Q4 | 14.14 Million CNY | 0.0% |
| 2014 Q2 | 12.59 Million CNY | -0.0% |
| 2014 Q1 | 12.59 Million CNY | 11.81% |
| 2014 FY | 56.3 Million CNY | 34.39% |
| 2013 Q4 | 11.26 Million CNY | 0.0% |
| 2013 FY | 41.89 Million CNY | 24.99% |
| 2012 FY | 33.52 Million CNY | 0.0% |